Personal information

Verified email domains

Activities

Employment (5)

University of Liverpool: Liverpool, Merseyside, GB

2015-11 to present | Professor (Institute of Infection and Global Health)
Employment
Source: Self-asserted source
Melita Gordon

University of Liverpool: Liverpool, Merseyside, GB

2012-10 to 2015-10 | Reader
Employment
Source: Self-asserted source
Melita Gordon

University of Liverpool: Liverpool, Merseyside, GB

2008-09 to 2012-10 | Senior Clinical Lecturer
Employment
Source: Self-asserted source
Melita Gordon

University of Liverpool: Liverpool, Merseyside, GB

2005-09 to 2008-10 | Clinical Lecturer
Employment
Source: Self-asserted source
Melita Gordon

University of Liverpool: Liverpool, Merseyside, GB

2000-09 to 2005-08 | Wellcome Trust Fellow
Employment
Source: Self-asserted source
Melita Gordon

Education and qualifications (8)

Royal College of Physicians: London, GB

2012-06-01 to present | FRCP (n/a)
Education
Source: Self-asserted source
Melita Gordon

Higher Education Academy: York, GB

2012-06-01 to 2014-06-01 | FHEA
Qualification
Source: Self-asserted source
Melita Gordon

University of Liverpool: Liverpool, GB

2001-09-01 to 2008-06-01 | MD doctoral thesis in Medical Sciences (Gastroenterology)
Education
Source: Self-asserted source
Melita Gordon

Liverpool School of Tropical Medicine: Liverpool, GB

1993-09-01 to 1993-12-20 | DTM&H (Clinical Medicine)
Education
Source: Self-asserted source
Melita Gordon

University of Cambridge: Cambridge, GB

1993-06-01 to 1993-06-02 | MA Medical Sciences (Churchill College)
Qualification
Source: Self-asserted source
Melita Gordon

Royal College of Physicians: London, GB

1993-05-01 to 1993-05-02 | MRCP (London) (n/a)
Qualification
Source: Self-asserted source
Melita Gordon

University of Oxford: Oxford, GB

1987-09-01 to 1990-06-01 | BMBCh (Green College)
Education
Source: Self-asserted source
Melita Gordon

University of Cambridge: Cambridge, GB

1984-10-01 to 1987-06-01 | BA Medical Sciences (Churchill College)
Education
Source: Self-asserted source
Melita Gordon

Professional activities (12)

World Health Organization: Geneva, CH

2021-11-01 to present | Invited expert, iNTS Vaccine Consultation process
Invited position
Source: Self-asserted source
Melita Gordon

Gavi: Geneva, CH

2020-03-01 to present | Independent Review Committee expert member
Invited position
Source: Self-asserted source
Melita Gordon

World Gastroenterology Organisation: WI, WI, US

2017-06-01 to present | Director, Malawi Training Centre in Gastroenterology
Invited position
Source: Self-asserted source
Melita Gordon

Gordon Research Conferences: Kingston, Rhode Island, US

2023-07-01 | Plenary Speaker
Distinction
Source: Self-asserted source
Melita Gordon

British Infection Association: Knutsford, GB

2023-05-01 | Plenary speaker
Distinction
Source: Self-asserted source
Melita Gordon

NIHR Academy: Leeds, GB

2019-12-01 | Research Professorship in Global Health
Distinction
Source: Self-asserted source
Melita Gordon

Sabin Vaccine Institute: Washington D.C., District of Columbia, US

2012-03-01 | Scientific Organising committee, Coalition Against Typhoid, 2012 onwards
Distinction
Source: Self-asserted source
Melita Gordon

British Society of Gerontology: London, GB

2011-03-01 | Sir Francis Avery Jones Research Medal (British Society of Gastroenterology)
Distinction
Source: Self-asserted source
Melita Gordon

NIHR Clinical Research Network: Leeds, GB

2008-09-01 | Wallport Senior Clinical Lecturer fellowship
Distinction
Source: Self-asserted source
Melita Gordon

Wellcome Trust: London, GB

1999-09-01 | Research Training Fellowship in Clinical Medicine
Distinction
Source: Self-asserted source
Melita Gordon

Liverpool School of Tropical Medicine: Liverpool, GB

1993-12-01 | Blacklock Medal for Parasitology
Distinction
Source: Self-asserted source
Melita Gordon

University of Oxford: Oxford, GB

1990-06-01 | Dalrymple-Champney Prize (Green College)
Distinction
Source: Self-asserted source
Melita Gordon

Funding (25)

TRIPLE STUDY - A PHASE 2A IMMUNOGENECITY AND TOLERABILITY STUDY OF A TRIVALENT VACCINE AGAINST INVASIVE SALMONELLA DISEASE

2023-06 to 2024-08 | Grant
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (MA, MA, US)
Source: Self-asserted source
Melita Gordon

ACCELERATING ACCESS TO TYPHOID CONJUGATE VACCINES (TYVAC 2.0) (TYVAC 2.0)

2022-01 to 2024-10 | Grant
Bill & Melinda Gates Foundation (Seattle, Washington, US)
Source: Self-asserted source
Melita Gordon

Development of an invasive non-typhoidal Salmonella human challenge model

2021-04-01 to 2024-03-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

224029/Z/21/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Seroepidemiology in Africa for iNTS vaccine (SAiNTS)

2020-10-01 to 2023-09-30 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

221135/Z/20/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

OptiVaNTS – Optimising Vaccination for iNTS disease in Africa

2020-09-01 to 2023-08-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

221431/Z/20/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Preventing Invasive Salmonella Disease in Africa

2019-12-01 to 2024-11-30 | Grant
NIHR Academy (Leeds, GB)
GRANT_NUMBER: NIHR300039
Source: Self-asserted source
Melita Gordon via DimensionsWizard

Vacc-iNTS - ADVANCING A GMMA-BASED VACCINE AGAINST INVASIVE NON-TYPHOIDAL SALMONELLOSIS THROUGH PHASE I TRIAL IN EUROPE AND SUB-SAHARAN AFRICA

2019-10 to 2024-09 | Grant
European Commission (Brussels, BE)
Source: Self-asserted source
Melita Gordon

Malawi Liverpool Wellcome Trust Programme - Core Award

2018-03-01 to 2023-03-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

206545/Z/17/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Malawi Liverpool Wellcome Trust Programme - Building Construction Capital Award

2018-01-01 to 2022-12-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

206545/A/17/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Health Priorities in Resource-Limited Settings

2017-09-01 to 2024-09-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

203919/Z/16/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Health Priorities in Resource-Limited Settings

2017-09-01 to 2022-09-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

102144/Z/13/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

TyVAC: Accelerating availability and access to Typhoid Conjugate Vaccines

2017-09 to 2021-05 | Grant
Bill and Melinda Gate Foundation (Seattle, WN, US)
GRANT_NUMBER: OPP1151153
Source: Self-asserted source
Melita Gordon

Health priorities in resource-limited settings

2017-07-27 to 2018-07-27 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

102144/Z/13/C

Source: Self-asserted source
Melita Gordon via DimensionsWizard

Emergency detection of chronic carriers after a typhoid outbreak

2016-10 to 2018-03 | Grant
Bill and Melinda Gates Foundation (WA, WA, US)
Source: Self-asserted source
Melita Gordon

Prevalence of Cryptosporidium in HIV-infected adults with diarrhoea in Malawi

2016-05 to 2018-04 | Grant
Bill and Melinda Gates Foundation (WA, WA, US)
Source: Self-asserted source
Melita Gordon

International Training Centre in Gastroenterology

2016-03 to 2020-03 | Award
British Society of Gastroenterology (London, GB)
Source: Self-asserted source
Melita Gordon

Enhanced evidence of typhoid fever transmission dynamics in populations

2016-01 to 2019-12 | Grant
Bill and Melinda Gates Foundation (WA, WA, US)
Source: Self-asserted source
Melita Gordon

Impact of maternally derived antibodies and infant microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants.

2015-07-12 to 2018-12-31 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/N006259/1
Source: Self-asserted source
Melita Gordon via DimensionsWizard

Health priorities in resource-limited settings

2015-07-09 to 2019-12-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

102144/Z/13/A

Source: Self-asserted source
Melita Gordon via DimensionsWizard

iNTS knowledge gaps in transmission, exposure and diagnosis

2015-07 to 2017-08 | Grant
Bill and Melinda Gates Foundation (WA, WA, US)
Source: Self-asserted source
Melita Gordon

Non-specific beneficial effects of typhoid vaccination

2015-05 to 2016-06 | Grant
Rosetrees Foundation (London, GB)
Source: Self-asserted source
Melita Gordon

A strategic vision to drive the control of enteric fever through vaccination

2015-03-01 to 2020-02-28 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

106158/Z/14/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

MICA: Study of disease mechanisms in enteric fever to characterise innate & adaptive immunity in mucosa & blood in controlled human infection model

2013-08-31 to 2019-08-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/K021222/1
Source: Self-asserted source
Melita Gordon via DimensionsWizard

The mechanism of recurrent non-typhi salmonella (NTS) bacteraemia in HIV-1 infected Malawian adults.

2000-12-01 to 2004-11-30 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

060150/B/00/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard

The mechanism of recurrent non-typhi salmonella (NTS) bacteraemia in HIV-1 infected Malawian adults.

2000-11-01 to 2005-12-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

060150/A/00/Z

Source: Self-asserted source
Melita Gordon via DimensionsWizard